Plasma MMP-9 - A marker of carotid plaque instability

80Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Objectives: to investigate whether peripheral blood levels of matrix mettaloproteinases (MMPs) or their inhibitors are altered in patients with particulate cerebral embolisation. Design: a prospective study. Materials and methods: using sandwich enzyme immunoassay, plasma levels of MMPs-1, -2, -3 and -9, plus TIMPs-1 and -2 were quantified in 70 consecutive patients undergoing carotid endarterectomy. Patients were monitored with transcranial Doppler (TCD) preoperatively and during the dissection phase of the operation to detect those with spontaneous particulate embolisation (n=21). Results: the plasma level of MMP-9 was significantly higher in those patients with evidence of spontaneous embolisation compared to those without. There were no differences in other MMP levels, or plasma concentrations of TIMPs. Conclusions: plasma MMP-9 levels are elevated in patients with particulate cerebral embolisation, and this may represent a novel marker of atherosclerotic plaque instability.

Cite

CITATION STYLE

APA

Loftus, I. M., Naylor, A. R., Bell, P. R. F., & Thompson, M. M. (2001). Plasma MMP-9 - A marker of carotid plaque instability. European Journal of Vascular and Endovascular Surgery, 21(1), 17–21. https://doi.org/10.1053/ejvs.2000.1278

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free